
| FUND | HOLDING | % OF FUND | VALUE ($) |
|---|---|---|---|
IXJ | Eli Lilly and (LLY) | 10.797% | $483.6M |
IXJ | Johnson & Johnson (JNJ) | 6.309% | $282.6M |
IXJ | AbbVie (ABBV) | 5.087% | $227.9M |
IXJ | UnitedHealth (UNH) | 3.764% | $168.6M |
IXJ | Merck (MRK) | 3.184% | $142.6M |
IXJ | Abbott Laboratories (ABT) | 2.763% | $123.8M |
IXJ | Thermo Fisher Scientific (TMO) | 2.711% | $121.4M |
IXJ | Intuitive Surgical (ISRG) | 2.575% | $115.3M |
IXJ | Amgen (AMGN) | 2.237% | $100.2M |
IXJ | Gilead Sciences (GILD) | 1.949% | $87.3M |
IXJ | Pfizer (PFE) | 1.817% | $81.4M |
IXJ | Boston Scientific (BSX) | 1.799% | $80.6M |
IXJ | Danaher (DHR) | 1.794% | $80.4M |
IXJ | Medtronic (MDT) | 1.605% | $71.9M |
IXJ | Stryker (SYK) | 1.551% | $69.5M |
IXJ | Vertex Pharmaceuticals (VRTX) | 1.469% | $65.8M |
IXJ | Bristol-Myers Squibb (BMY) | 1.4% | $62.7M |
IXJ | McKesson (MCK) | 1.289% | $57.7M |
IXJ | CVS Health (CVS) | 1.247% | $55.9M |
IXJ | Regeneron Pharmaceuticals (REGN) | 0.988% | $44.3M |
IXJ | Elevance Health (ELV) | 0.961% | $43M |
IXJ | HCA (HCA) | 0.959% | $43M |
IXJ | Cigna (CI) | 0.919% | $41.2M |
IXJ | CoreSite Realty (COR) | 0.835% | $37.4M |
IXJ | BlackRock Cash Funds Treasury SL Agency | 0.816% | $36.6M |